Internal Medicine, Endocrinology, Diabetes, & Metabolism · Capitola, CA
NPI
1548243827
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
815 Bay Ave, Suite B
Capitola, CA, 95010
Phone (831) 460-7333
Groups this clinician bills Medicare through
Medicare paid, 2024
$324K
19,305 services
Medicare patients, 2024
479
Average age 74
Drug cost, 2024
$1.6M
3,626 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gursharan K Gill was code J3111 (injection, romosozumab-aqqg, 1 mg), 12,600 times for 17 patients. In total Gursharan K Gill billed 19,305 services in 27 codes, and Medicare paid $324K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-11-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 12,600 | 17 | $8.47 | $107K |
| J0897 Injection, denosumab, 1 mg | Office | 3,060 | 31 | $20.61 | $63K |
| 99214 Office E&M - Established | Office | 514 | 309 | $100.49 | $52K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 382 | 201 | $13.29 | $5,075 |
| 95251 Test - Miscellaneous | Office | 283 | 128 | $27.26 | $7,714 |
| 99215 Office E&M - Established | Office | 202 | 146 | $143.83 | $29K |
| 96372 Injection Administration | Office | 194 | 52 | $12.44 | $2,413 |
| 99213 Office E&M - Established | Office | 148 | 125 | $68.34 | $10K |
| 83036 Blood Count | Office | 40 | 33 | $9.52 | $381 |
| 99205 Office E&M - New | Office | 27 | 27 | $171.34 | $4,626 |
| 99204 Office E&M - New | Office | 22 | 22 | $131.93 | $2,902 |
| G0008 Administration of influenza virus vaccine | Office | 18 | 18 | $34.63 | $623 |
| 90653 Vaccine Product | Office | 16 | 16 | $81.82 | $1,309 |
By year: 2022 $254K for 16,020 services; 2023 $280K for 19,254 services; 2024 $324K for 19,305 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 40 | 33 | $9.52 | $381 |
Medicare prescription drug claims, 2024
In 2024, the drug Gursharan K Gill prescribed most often to Medicare patients was Levothyroxine Sodium, with 334 prescriptions and refills. In total Gursharan K Gill wrote 3,626 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 334 | 962 | 101 | $4,573 |
| Synthroid Levothyroxine Sodium | 230 | 648 | 66 | $25K |
| Jardiance Empagliflozin | 180 | 430 | 47 | $243K |
| Metformin Hcl Generic | 145 | 381 | 43 | $3,937 |
| Metformin Hcl Er Metformin Hcl | 139 | 389 | 49 | $2,285 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 129 | 328 | 42 | $17K |
| Atorvastatin Calcium Generic | 106 | 298 | 32 | $1,147 |
| Ozempic Semaglutide | 106 | 184 | 28 | $175K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 97 | 258 | 46 | $9,168 |
| Mounjaro Tirzepatide | 92 | 151 | 22 | $156K |
| Humalog Kwikpen U-100 Insulin Lispro | 88 | 182 | 35 | $27K |
| Trulicity Dulaglutide | 83 | 140 | 19 | $131K |
| Tirosint Levothyroxine Sodium | 81 | 202 | 18 | $26K |
| Repaglinide Generic | 79 | 207 | 28 | $5,816 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 73 | 130 | 18 | $69K |
Brand drugs: 1,961 claims; generic drugs: 1,314 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Gursharan K Gill were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.